Leiomyosarcoma

descriptionPublicationkeyboard_double_arrow_right Article 01 Oct 2013 English Publisher:Elsevier BVJournal:Hematology/Oncology Clinics of North America, volume 27, pages 957-974 (issn: 0889-8588,

Authors: César, Serrano; Suzanne, George;

doi: 10.1016/j.hoc.2013.07.002

pmid: 24093170

Leiomyosarcoma

- Summary
- Subjects
- Metrics

Abstract

This article presents an overview of the current literature about the biology, pathology, and the clinical management of leiomyosarcoma. In addition, the article emphasizes and discusses the current systemic treatment options available for patients with leiomyosarcoma, which range from cytotoxic chemotherapy to target therapies. Particular leiomyosarcoma subtypes, such as uterine leiomyosarcoma and inferior vena cava leiomyosarcoma, are discussed separately.

Related Organizations

Dana-Farber Cancer Institute
United States
Brigham and Women's Faulkner Hospital
United States
Sarcoma Oncology Center
United States

Keywords

Leiomyosarcoma, Humans

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	136
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 1%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 1%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%